Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 3/2011

01.06.2011

Improving Efficiency in the Nuclear Cardiology Laboratory: The Role of Stress-Only Imaging Coupled with Faster Acquisition Protocols and New Stressor Agents

verfasst von: John J. Mahmarian

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Laboratory efficiency is an important benchmark to achieve whether imaging is hospital-based or in the private practice setting. The stressor and imaging protocols used and the camera systems available for imaging all play a pivotal role toward this end. A same-day low-dose rest/high-dose stress imaging protocol has been widely adopted in nuclear cardiology laboratories. However, recent studies indicate that rest imaging may be unnecessary in patients with a normal initial stress single photon emission CT (SPECT) study. Appropriate elimination of rest imaging would decrease costs, streamline patient evaluations, and significantly reduce radiation exposure. Several recent studies have validated the safety of stress-only imaging in patients who have an initially normal perfusion study. Combined with new pharmacologic stressor agents and camera systems that can complete imaging within minutes, laboratory efficiency and patient satisfaction should improve considerably. The following article will review these currently available advances in SPECT imaging.
Literatur
1.
Zurück zum Zitat Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318–33.PubMedCrossRef Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318–33.PubMedCrossRef
2.
Zurück zum Zitat Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171–85.PubMedCrossRef Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171–85.PubMedCrossRef
3.
Zurück zum Zitat Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004;94:33D–40.PubMedCrossRef Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004;94:33D–40.PubMedCrossRef
4.
Zurück zum Zitat Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58.PubMedCrossRef Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58.PubMedCrossRef
5.
Zurück zum Zitat Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol. 2007;14:514–20.PubMedCrossRef Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol. 2007;14:514–20.PubMedCrossRef
6.
Zurück zum Zitat Udelson JE, Heller GV, Wackers FJ, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation. 2004;109:457–64.PubMedCrossRef Udelson JE, Heller GV, Wackers FJ, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation. 2004;109:457–64.PubMedCrossRef
7.
Zurück zum Zitat Udelson JE, Iteld BJ, Weiland FL, et al. Double-blinded comparison of the side effects associated with pharmacologic stress induced with binodenoson and adenosine (abstr). J Nucl Cardiol. 2008;15:S17–8.CrossRef Udelson JE, Iteld BJ, Weiland FL, et al. Double-blinded comparison of the side effects associated with pharmacologic stress induced with binodenoson and adenosine (abstr). J Nucl Cardiol. 2008;15:S17–8.CrossRef
8.
Zurück zum Zitat •• Cerqueira MD, Nguyen P, Staehr P, et al.: Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008, 1:307–316. The ADVANCE-MPI were two pivotal trials which demonstrated the non-inferiority of regadenoson as compared to adenosine myocardial perfusion imaging. These two trials led to FDA approval of regadenoson as a pharmacologic stressor agent. PubMedCrossRef •• Cerqueira MD, Nguyen P, Staehr P, et al.: Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008, 1:307–316. The ADVANCE-MPI were two pivotal trials which demonstrated the non-inferiority of regadenoson as compared to adenosine myocardial perfusion imaging. These two trials led to FDA approval of regadenoson as a pharmacologic stressor agent. PubMedCrossRef
9.
Zurück zum Zitat • Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al.: Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2009, 2:959–968. This substudy of the ADVANCE-MPI 2 trial used quantitative polar plot analysis to demonstrate that regadenoson induces total and ischemic perfusion defects of comparable size as adenosine. These results infer that regadenoson perfusion results should result in comparable diagnostic and prognostic information as that obtained with adenosine stress. PubMedCrossRef • Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al.: Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2009, 2:959–968. This substudy of the ADVANCE-MPI 2 trial used quantitative polar plot analysis to demonstrate that regadenoson induces total and ischemic perfusion defects of comparable size as adenosine. These results infer that regadenoson perfusion results should result in comparable diagnostic and prognostic information as that obtained with adenosine stress. PubMedCrossRef
10.
Zurück zum Zitat Murray JJ, Weiler JM, Schwartz LB, et al. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circ Cardiovasc Imaging. 2009;2:492–8.PubMedCrossRef Murray JJ, Weiler JM, Schwartz LB, et al. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circ Cardiovasc Imaging. 2009;2:492–8.PubMedCrossRef
11.
Zurück zum Zitat Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008;15:319–28.PubMedCrossRef Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008;15:319–28.PubMedCrossRef
12.
Zurück zum Zitat Leaker BR, O'Connor B, Hansel TT, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol. 2008;15:329–36.PubMedCrossRef Leaker BR, O'Connor B, Hansel TT, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol. 2008;15:329–36.PubMedCrossRef
13.
Zurück zum Zitat Aljaroudi W, Hermann D, Hage F, et al. Safety of regadenoson in patients with end-stage renal disease. Am J Cardiol. 2010;105:133–5.PubMedCrossRef Aljaroudi W, Hermann D, Hage F, et al. Safety of regadenoson in patients with end-stage renal disease. Am J Cardiol. 2010;105:133–5.PubMedCrossRef
14.
Zurück zum Zitat Gaemperli O, Schepis T, Koepfli P, et al. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol. 2008;51:328–9.PubMedCrossRef Gaemperli O, Schepis T, Koepfli P, et al. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol. 2008;51:328–9.PubMedCrossRef
15.
Zurück zum Zitat Hansen CL, Goldstein RA, Akinboboye OO, et al. Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol. 2007;14:e39–60.PubMedCrossRef Hansen CL, Goldstein RA, Akinboboye OO, et al. Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol. 2007;14:e39–60.PubMedCrossRef
16.
Zurück zum Zitat Henzlova MJ, Cerqueira MD, Mahmarian JJ, et al. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80–90.PubMedCrossRef Henzlova MJ, Cerqueira MD, Mahmarian JJ, et al. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80–90.PubMedCrossRef
17.
Zurück zum Zitat Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99 m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69–77.PubMedCrossRef Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99 m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69–77.PubMedCrossRef
18.
Zurück zum Zitat Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures (editorial). J Nucl Cardiol. 2006;13:19–23.PubMedCrossRef Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures (editorial). J Nucl Cardiol. 2006;13:19–23.PubMedCrossRef
19.
Zurück zum Zitat Laskey WK, Feinendegen LE, Neumann RD, Dilsizian V. Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging. 2010;3:517–24.PubMedCrossRef Laskey WK, Feinendegen LE, Neumann RD, Dilsizian V. Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging. 2010;3:517–24.PubMedCrossRef
20.
Zurück zum Zitat DesPrez RD, Dahlberg ST, Einstein AJ, et al.: Stress-only myocardial perfusion imaging. 2009 clinical update. Available at http://www.asnc.org. Accessed March 2010 DesPrez RD, Dahlberg ST, Einstein AJ, et al.: Stress-only myocardial perfusion imaging. 2009 clinical update. Available at http://​www.​asnc.​org. Accessed March 2010
21.
Zurück zum Zitat Gibson PB, Demus D, Noto R, et al. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol. 2002;39:999–1004.PubMedCrossRef Gibson PB, Demus D, Noto R, et al. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol. 2002;39:999–1004.PubMedCrossRef
22.
Zurück zum Zitat Gal R, Ahmad M. Cost-saving approach to normal technetium-99 m sestamibi myocardial perfusion scan. Am J Cardiol. 1996;78:1047–9.PubMedCrossRef Gal R, Ahmad M. Cost-saving approach to normal technetium-99 m sestamibi myocardial perfusion scan. Am J Cardiol. 1996;78:1047–9.PubMedCrossRef
23.
Zurück zum Zitat Bateman TM, Heller GV, McGhie AI, et al. Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress Tc-99 m SPECT imaging. J Nucl Cardiol. 2009;16:726–35.PubMedCrossRef Bateman TM, Heller GV, McGhie AI, et al. Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress Tc-99 m SPECT imaging. J Nucl Cardiol. 2009;16:726–35.PubMedCrossRef
24.
Zurück zum Zitat • Duvall WL, Wijetunga MN, Klein TM, et al.: The prognosis of a normal stress-only Tc-99 m myocardial perfusion imaging study. J Nucl Cardiol 2010, 17:370–377. This study demonstrated the feasibility of stress-only imaging and that a normal stress-only study predicts the same low risk as a standard rest-stress study. PubMedCrossRef • Duvall WL, Wijetunga MN, Klein TM, et al.: The prognosis of a normal stress-only Tc-99 m myocardial perfusion imaging study. J Nucl Cardiol 2010, 17:370–377. This study demonstrated the feasibility of stress-only imaging and that a normal stress-only study predicts the same low risk as a standard rest-stress study. PubMedCrossRef
25.
Zurück zum Zitat •• Chang SM, Nabi F, Xu J, et al.: Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 2010, 55:221–230. This is a 16,000-patient study demonstrating the safety of a normal stress-only versus a normal stress-rest myocardial perfusion study, with similar patient outcomes irrespective of the imaging protocol or patient profile. This study demonstrated a 61% lower radiopharmaceutical dosage with stress-only versus conventional stress-rest imaging. PubMedCrossRef •• Chang SM, Nabi F, Xu J, et al.: Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 2010, 55:221–230. This is a 16,000-patient study demonstrating the safety of a normal stress-only versus a normal stress-rest myocardial perfusion study, with similar patient outcomes irrespective of the imaging protocol or patient profile. This study demonstrated a 61% lower radiopharmaceutical dosage with stress-only versus conventional stress-rest imaging. PubMedCrossRef
26.
Zurück zum Zitat Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.PubMedCrossRef Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.PubMedCrossRef
27.
Zurück zum Zitat Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.PubMedCrossRef Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.PubMedCrossRef
28.
Zurück zum Zitat Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551–61.PubMedCrossRef Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551–61.PubMedCrossRef
29.
Zurück zum Zitat Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 1994;137(2 Suppl):S68–97.CrossRef Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 1994;137(2 Suppl):S68–97.CrossRef
30.
Zurück zum Zitat Radiation dose to patients from radiopharmaceuticals. (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997. Ann ICRP. 1998;28:1–126. Radiation dose to patients from radiopharmaceuticals. (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997. Ann ICRP. 1998;28:1–126.
32.
Zurück zum Zitat Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol. 2009;54:1872–82.PubMedCrossRef Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol. 2009;54:1872–82.PubMedCrossRef
33.
Zurück zum Zitat • Maddahi J, Mendez R, Mahmarian JJ, et al.: Prospective multicenter evaluation of rapid, gated SPECT myocardial perfusion upright imaging. J Nucl Cardiol 2009, 16:351–357. This was one of the first studies to address the feasibility and comparable image quality of half-time versus full-time imaging. PubMedCrossRef • Maddahi J, Mendez R, Mahmarian JJ, et al.: Prospective multicenter evaluation of rapid, gated SPECT myocardial perfusion upright imaging. J Nucl Cardiol 2009, 16:351–357. This was one of the first studies to address the feasibility and comparable image quality of half-time versus full-time imaging. PubMedCrossRef
34.
Zurück zum Zitat • Venero CV, Heller GV, Bateman TM, et al.: A multicenter evaluation of a new post-processing method with depth-dependent collimator resolution applied to full-time and half-time acquisitions without and with simultaneously acquired attenuation correction. J Nucl Cardiol 2009, 16:714–725. This study demonstrated comparable image quality with half-time imaging using concomitant iterative reconstruction as compared to standard filtered back projection. PubMedCrossRef • Venero CV, Heller GV, Bateman TM, et al.: A multicenter evaluation of a new post-processing method with depth-dependent collimator resolution applied to full-time and half-time acquisitions without and with simultaneously acquired attenuation correction. J Nucl Cardiol 2009, 16:714–725. This study demonstrated comparable image quality with half-time imaging using concomitant iterative reconstruction as compared to standard filtered back projection. PubMedCrossRef
35.
Zurück zum Zitat DePuey EG, Gadiraju R, Clark J, et al. Ordered subset expectation maximization and wide beam reconstruction “half-time” gated myocardial perfusion SPECT functional imaging: a comparison to “full-time” filtered backprojection. J Nucl Cardiol. 2008;15:547–63.PubMedCrossRef DePuey EG, Gadiraju R, Clark J, et al. Ordered subset expectation maximization and wide beam reconstruction “half-time” gated myocardial perfusion SPECT functional imaging: a comparison to “full-time” filtered backprojection. J Nucl Cardiol. 2008;15:547–63.PubMedCrossRef
36.
Zurück zum Zitat Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255–76.PubMedCrossRef Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255–76.PubMedCrossRef
37.
Zurück zum Zitat • Sharir T, Slomka PJ, Hayes SW, et al.: Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function. J Am Coll Cardiol 2010, 55:1965–1974. Using the novel D-SPECT rapid imaging system, comparable quantitative total and ischemic perfusion defect sizes were obtained as seen with conventional imaging. PubMedCrossRef • Sharir T, Slomka PJ, Hayes SW, et al.: Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function. J Am Coll Cardiol 2010, 55:1965–1974. Using the novel D-SPECT rapid imaging system, comparable quantitative total and ischemic perfusion defect sizes were obtained as seen with conventional imaging. PubMedCrossRef
38.
Zurück zum Zitat Garcia EV, Tsukerman L, Keidar Z. A new solid state, ultra fast cardiac multi-detector SPECT system (abstr). J Nucl Cardiol. 2008;15:S3.CrossRef Garcia EV, Tsukerman L, Keidar Z. A new solid state, ultra fast cardiac multi-detector SPECT system (abstr). J Nucl Cardiol. 2008;15:S3.CrossRef
39.
Zurück zum Zitat Esteves FP, Raggi P, Folks RD, et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol. 2009;16:927–34.PubMedCrossRef Esteves FP, Raggi P, Folks RD, et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol. 2009;16:927–34.PubMedCrossRef
Metadaten
Titel
Improving Efficiency in the Nuclear Cardiology Laboratory: The Role of Stress-Only Imaging Coupled with Faster Acquisition Protocols and New Stressor Agents
verfasst von
John J. Mahmarian
Publikationsdatum
01.06.2011
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 3/2011
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-011-9084-6

Weitere Artikel der Ausgabe 3/2011

Current Cardiovascular Imaging Reports 3/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.